Halberd EPS
Laba per Saham (EPS) dari Halberd (HALB) pada 14 Agu 2026.
Get this data via API
Financial Data API
EPS
-0,00USD
YoY
-77,35%
Terakhir Diperbarui:
Laba per Saham (EPS) dari Halberd adalah 2026 -0,00 USD. Laba per Saham (EPS) dari Halberd adalah 2025 -0,00 USD. Menurun -77,35% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API
Halberd Analisis saham
Apa yang dilakukan Halberd? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide.
A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics.
Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities.
Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits.
In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector.
Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd adalah salah satu perusahaan paling populer di Eulerpool.
Pertanyaan yang Sering Diajukan tentang saham Halberd
Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Laba per Saham (EPS) Halberd sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.
Laba per Saham mengukur porsi laba perusahaan yang dialokasikan untuk setiap saham yang beredar. Metrik ini adalah metrik kunci untuk menilai profitabilitas perusahaan berdasarkan per saham.
EPS = Laba Bersih / Saham yang Beredar
Access this data via the Eulerpool API
Laporan Laba Rugi — Halberd
Semua Metrik Kunci — Halberd
Penilaian
Laporan Laba Rugi
Margin
Neraca
- Total Aset
- Aset Lancar
- Kas & Setara Kas
- Piutang
- Persediaan
- Properti, Pabrik & Peralatan
- Goodwill
- Aset Tidak Berwujud
- Modal sendiri
- Utang
- Utang
- Kewajiban Lancar
- Utang Jangka Panjang
- Utang Jangka Pendek
- Laba Ditahan
- Nilai Buku per Saham
- Nilai Buku Berwujud per Saham
- Modal Kerja
- Investasi
- Hutang Usaha
- Aset Tidak Lancar
- Investasi Jangka Pendek
- Investasi Jangka Panjang
- Utang Bersih
- Saham Treasuri
- Kepentingan Minoritas
- Kewajiban Pajak Tangguhan
- Aset Berwujud Bersih
- Goodwill/Aset
- Aset Tidak Berwujud/Aset
Arus Kas
- Aliran Kas Operasional
- Pengeluaran Modal
- Aliran Kas Bebas
- FCF per Saham
- Dividen yang Dibayarkan
- Pembelian Kembali Saham
- Aliran Kas Investasi
- Aliran Kas Pendanaan
- CapEx / Pendapatan
- Aliran Kas per Saham
- Kompensasi Berbasis Saham
- Perubahan Modal Kerja
- Akuisisi (Bersih)
- Perubahan Kas Bersih
- CapEx/Arus Kas Operasional
- FCF/Laba Bersih
- Konversi FCF
- Konversi Kas
- Total Pembayaran Pemegang Saham
- CapEx/Penyusutan & Amortisasi
Profitabilitas
- ROE
- ROA
- ROCE
- ROIC
- Perputaran Aset
- Perputaran Persediaan
- Perputaran Piutang
- Hari Penjualan Beredar
- Hari Persediaan Beredar
- Hari Hutang Beredar
- Siklus Konversi Kas
- CROIC
- Laba Kotor/Aset
- Perputaran Aset Tetap
- Perputaran Ekuitas
- Perputaran Modal Kerja
- Perputaran Utang Dagang
- Intensitas Modal
- Piutang/Pendapatan
- Persediaan/Pendapatan
- EBIT/Aset
Leverage
Pertumbuhan
- Pertumbuhan Pendapatan
- CAGR Pendapatan 3T
- CAGR Pendapatan 5T
- CAGR Pendapatan 10T
- Pertumbuhan Laba
- Pertumbuhan EPS
- Pertumbuhan EBIT
- EBIT CAGR 3T
- EBIT CAGR 5T
- EBIT CAGR 10T
- Pertumbuhan Dividen
- Pertumbuhan FCF
- Pertumbuhan Nilai Buku
- Earnings CAGR 3T
- Earnings CAGR 5T
- Earnings CAGR 10T
- EPS CAGR 3T
- EPS CAGR 5T
- Pertumbuhan EBITDA YoY
- EBITDA CAGR 3T
- EBITDA CAGR 5T
- Pertumbuhan Laba Kotor
- Pertumbuhan OCF YoY
- Pertumbuhan Karyawan
- Dividend CAGR 3T
- Dividend CAGR 5T
- Dividend CAGR 10T
- Pertumbuhan Aset
- Pertumbuhan Ekuitas
- Pertumbuhan Utang
- Pertumbuhan CapEx
- FCF CAGR 3T
- FCF CAGR 5T
- Pertumbuhan Kapitalisasi Pasar
- Pertumbuhan Jumlah Saham